SCHEMBL6169816

SCHEMBL6169816

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)C(CC)Cc2ccc(F)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
EPHX2 P34913 2/20 0.48
PPARG P37231 2/20 0.48
RAB9A P51151 3/20 0.47
ALDH1A1 P00352 5/20 0.47
MAPT P10636 4/20 0.47
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 2/20 0.46
PTGER4 P35408 1/20 0.45
MEN1 O00255 3/20 0.42
CASP3 P42574 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
THRB P10828 1/20 0.42
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172669 0.90 KMT2A (0.52) KMT2AEPHX2PPARGRAB9AALDH1A1
SCHEMBL6169030 0.90 KMT2A (0.52) KMT2AEPHX2PPARGRAB9AALDH1A1
SCHEMBL6169814 0.90 KMT2A (0.48) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6172416 0.85 KMT2A (0.48) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6169116 0.84 KMT2A (0.48) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6168615 0.82 POLB (0.54) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6170738 0.82 KMT2A (0.49) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6170279 0.81 KMT2A (0.48) KMT2AEPHX2RAB9AALDH1A1MAPT
SCHEMBL7671189 0.80 KMT2A (0.48) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6170341 0.80 KMT2A (0.59) KMT2ARAB9AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed